These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34276544)

  • 1. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.
    Bluett B; Pantelyat AY; Litvan I; Ali F; Apetauerova D; Bega D; Bloom L; Bower J; Boxer AL; Dale ML; Dhall R; Duquette A; Fernandez HH; Fleisher JE; Grossman M; Howell M; Kerwin DR; Leegwater-Kim J; Lepage C; Ljubenkov PA; Mancini M; McFarland NR; Moretti P; Myrick E; Patel P; Plummer LS; Rodriguez-Porcel F; Rojas J; Sidiropoulos C; Sklerov M; Sokol LL; Tuite PJ; VandeVrede L; Wilhelm J; Wills AA; Xie T; Golbe LI
    Front Neurol; 2021; 12():694872. PubMed ID: 34276544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Pantelyat A
    Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.
    Aiba I; Hayashi Y; Shimohata T; Yoshida M; Saito Y; Wakabayashi K; Komori T; Hasegawa M; Ikeuchi T; Tokumaru AM; Sakurai K; Murayama S; Hasegawa K; Uchihara T; Toyoshima Y; Saito Y; Yabe I; Tanikawa S; Sugaya K; Hayashi K; Sano T; Takao M; Sakai M; Fujimura H; Takigawa H; Adachi T; Hanajima R; Yokota O; Miki T; Iwasaki Y; Kobayashi M; Arai N; Ohkubo T; Yokota T; Mori K; Ito M; Ishida C; Tanaka M; Idezuka J; Kanazawa M; Aoki K; Aoki M; Hasegawa T; Watanabe H; Hashizume A; Niwa H; Yasui K; Ito K; Washimi Y; Mukai E; Kubota A; Toda T; Nakashima K;
    Brain Commun; 2023; 5(6):fcad296. PubMed ID: 38090279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 6. Caregiver strain in progressive supranuclear palsy and corticobasal syndromes.
    Kellermair L; Fuchs A; Eggers C; Schwingenschuh P; Kögl M; Fellner F; Forstner T; Mangesius S; Guger M; Ransmayr G
    J Neural Transm (Vienna); 2021 Oct; 128(10):1611-1621. PubMed ID: 34296340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep disturbances in progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS).
    Alster P; Madetko-Alster N; Migda A; Migda B; Kutyłowski M; Królicki L; Friedman A
    Neurol Neurochir Pol; 2023; 57(3):229-234. PubMed ID: 36928793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
    Satoh R; Weigand SD; Pham NTT; Ali F; Arani A; Senjem ML; Jack CR; Whitwell JL; Josephs KA
    Mov Disord; 2023 Dec; 38(12):2282-2290. PubMed ID: 37772771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology and emerging biomarkers in corticobasal syndrome.
    Koga S; Josephs KA; Aiba I; Yoshida M; Dickson DW
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(9):919-29. PubMed ID: 35697501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.
    Alster P; Madetko N; Migda B; Nieciecki M; Kutyłowski M; Królicki L; Friedman A
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.
    Lamb R; Rohrer JD; Lees AJ; Morris HR
    Curr Treat Options Neurol; 2016 Sep; 18(9):42. PubMed ID: 27526039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progressive supranuclear palsy: what's new?].
    Levy R
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):191-201. PubMed ID: 21690028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
    Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review.
    Burrell JR; Hodges JR; Rowe JB
    Mov Disord; 2014 Apr; 29(5):684-93. PubMed ID: 24757116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A; Sghaier I; Neji A; Gharbi A; Abida Y; Mrabet S; Gargouri A; Djebara MB; Kacem I; Gouider R
    J Mov Disord; 2024 Apr; 17(2):158-170. PubMed ID: 38290492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.
    Upadhyay N; Suppa A; Piattella MC; Bologna M; Di Stasio F; Formica A; Tona F; Colosimo C; Berardelli A; Pantano P
    J Neurol; 2016 Oct; 263(10):2022-31. PubMed ID: 27411806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.
    Seckin ZI; Duffy JR; Strand EA; Clark HM; Utianski RL; Machulda MM; Botha H; Ali F; Thu Pham NT; Lowe VJ; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2020 Dec; 81():34-40. PubMed ID: 33045651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.